Skip to content
DraconiticResearch
Search Sources API
203,234 studies31 sourcesUpdated 51 min ago
PreprintAll rights reservedmedRxiv

Defining a subgroup within autism leads to potential enrichment criteria in investigational therapeutic development: Comparing resting state gamma band power to a fragile X syndrome reference sample

  1. 1Cincinnati Children's Hospital Medical Center

Related

  1. BPC-157 as an Investigational Peptide Therapeutic: Biopharmaceutical Challenges, Formulation Strategies, and Translational Development Barriers
    Diana-Maria Mateescu, Dragos-Mihai Gavrilescu, Florin Eugen Constantinescu +7
    PharmaceuticsPeer-reviewedCC BY6 citedPharmacology & toxicologyOpenAlex
  2. Emerging natural product development strategies drive the therapeutic potential exploration and clinical translation of hydroxysafflor yellow A
    Haonan Zhu, Xiao Ni, Zhe Yu +7
    Journal of Pharmaceutical AnalysisPeer-reviewedCC BYFull text3 citedPharmacology & toxicologyDOAJ
  3. Exploring the potential of cold plasma for nitrogen enrichment in diverse soil types of Kerala
    Deepthi P., Prabha Susan Philip, Sudheer K.P. +2
    Scientific ReportsPeer-reviewedCC BY-NC-ND 4.0Full textMedical imaging & radiologyCrossref
  4. Comparing the Cutaneous Impacts of a Topical Restructuring Serum versus. Injected Hyaluronic Acid (HA) and Their Combination as Potential Anti-Aging Strategies in Chinese Women: An In Vivo Study
    Jing Li, Xingzuo Liu, Liang Zhang +10
    Dermatology and TherapyPeer-reviewedCC BY-NC 4.0Full textGeneral medicinePMCDOAJ
  5. Skin-Derived Non-Coding RNAs as Potential Biomarkers and Therapeutic Targets
    Non-coding RNAPeer-reviewedCC BYFull textMolecular biology & gene regulationOncologyEurope PMC
BibTeX
@misc{westercamp2026defining,
  title = {{Defining a subgroup within autism leads to potential enrichment criteria in investigational therapeutic development: Comparing resting state gamma band power to a fragile X syndrome reference sample}},
  author = {G. Westercamp and S. Sarraf and P. Vanderklish and S. Gargosky and E. Pedapati and C. Erickson},
  howpublished = {medRxiv},
  year = {2026},
  month = oct,
  doi = {10.64898/2026.10.06.26364877},
  url = {https://www.medrxiv.org/content/10.64898/2026.10.06.26364877v1},
}
RIS
TY  - UNPB
TI  - Defining a subgroup within autism leads to potential enrichment criteria in investigational therapeutic development: Comparing resting state gamma band power to a fragile X syndrome reference sample
AU  - G. Westercamp
AU  - S. Sarraf
AU  - P. Vanderklish
AU  - S. Gargosky
AU  - E. Pedapati
AU  - C. Erickson
PY  - 2026
DA  - 2026/10/06
PB  - medRxiv
DO  - 10.64898/2026.10.06.26364877
UR  - https://www.medrxiv.org/content/10.64898/2026.10.06.26364877v1
ER  -